NDAINTRAVENOUSSOLUTION
Approved
Mar 2020
Lifecycle
Peak
Competitive Pressure
15/100
Clinical Trials
6
Data completeness
3/8 — Basic
Drug data last refreshed 23h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRIFERIC AVNU (ferric pyrophosphate citrate) is an intravenous iron replacement therapy administered as a solution. It is indicated for iron replacement in patients with iron deficiency anemia, particularly those undergoing hemodialysis. The drug delivers iron directly via IV infusion to replenish depleted iron stores in patients who cannot tolerate or absorb oral iron effectively.
Peak3.0 years to LOE
Product is in peak commercial phase with no linked job openings currently, indicating stable but potentially maturing market position.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (6)
Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
Started Apr 2021
12 enrolled
End Stage Renal Disease
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
Started Sep 2020
150 enrolled
End Stage Renal Disease
Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
Started Jun 2020
23 enrolled
End Stage Renal Disease
Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
Started Oct 2017
27 enrolled
End Stage Renal Disease
Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
Started Apr 2016
13 enrolled
End Stage Renal Disease
Worked on TRIFERIC AVNU at Rockwell Medical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.